Literature DB >> 15999308

Matrix testing for urothelial tissue engineering.

L Wünsch1, E M Ehlers, M Russlies.   

Abstract

INTRODUCTION: Surgical reconstruction of the bladder is associated with many well-known complications. Tissue engineering is under discussion as a potential therapeutic strategy and many of the proposed benefits are of special interest for children. Biomaterials play a key role in tissue engineering. Many materials have been proposed for the experimental reconstruction of the bladder and urethra. They determine the biological and mechanical characteristics of the reconstructed tissues. Most publications focus on a single material. In order to identify the most suitable biomaterial it was the aim of this study to compare biological and mechanical features of different biomaterials seeded with urothelial cells in vitro.
MATERIALS AND METHODS: Commercially available biomaterials (Biogide, Ethisorb, Lyoplant, SIS, Vicryl, Xenoderm) of biologic or synthetic origin were seeded with urothelial cells. Cell-matrix constructs were cultured and investigated by scanning electron microscopy for surface structure and cell morphology. They were also subjected to extension until failure and the force required was reported as f (max). Values obtained and curve shape were compared to specimens of bladder mucosa and submucosa.
RESULTS: Cell adhesion and morphology showed marked differences between materials. Cell shape varied from single spherical cells to confluent layers of flat urothelium. f (max) ranged from 0.02 N to 48.86 N for tested materials and 1.19 N for native bladder mucosa/submucosa. DISCUSSION: The materials showed marked differences in biological and mechanical features in vitro. Cells cultured on biogenic matrices were more similar to native urothelium. Most of the tested materials showed different curve shapes and higher f (max) values than native bladder mucosa.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15999308     DOI: 10.1055/s-2004-830356

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  6 in total

1.  Assessment of essential characteristics of two different scaffolds for tendon in situ regeneration.

Authors:  Markus U Wagenhäuser; Matthias F Pietschmann; Denitsa Docheva; Mehmet F Gülecyüz; Volkmar Jansson; Peter E Müller
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-01-04       Impact factor: 4.342

2.  Characterizing and optimizing poly-L-lactide-co-ε-caprolactone membranes for urothelial tissue engineering.

Authors:  Reetta Sartoneva; Anne-Marie Haaparanta; Tuija Lahdes-Vasama; Bettina Mannerström; Minna Kellomäki; Minna Salomäki; George Sándor; Riitta Seppänen; Susanna Miettinen; Suvi Haimi
Journal:  J R Soc Interface       Date:  2012-08-15       Impact factor: 4.118

3.  Comparison of a poly-L-lactide-co-ε-caprolactone and human amniotic membrane for urothelium tissue engineering applications.

Authors:  Reetta Sartoneva; Suvi Haimi; Susanna Miettinen; Bettina Mannerström; Anne-Marie Haaparanta; George K Sándor; Minna Kellomäki; Riitta Suuronen; Tuija Lahdes-Vasama
Journal:  J R Soc Interface       Date:  2010-11-24       Impact factor: 4.118

4.  Bladder Augmentation Using Lyoplant®: First Experimental Results in Rats.

Authors:  F Winde; K Backhaus; J A Zeitler; N Schlegel; Th Meyer
Journal:  Tissue Eng Regen Med       Date:  2019-09-26       Impact factor: 4.169

5.  Supportive features of a new hybrid scaffold for urothelium engineering.

Authors:  Mohammad Naji; Javad Rasouli; Nasser Shakhssalim; Mohammad Mehdi Dehghan; Masoud Soleimani
Journal:  Arch Med Sci       Date:  2015-04-23       Impact factor: 3.318

6.  Biodegradable poly (lactic acid-co-glycolic acid) scaffolds as carriers for genetically-modified fibroblasts.

Authors:  Tatjana Perisic; Ziyang Zhang; Peter Foehr; Ursula Hopfner; Kathrin Klutz; Rainer H Burgkart; Alexei Slobodianski; Moritz Goeldner; Hans-Günther Machens; Arndt F Schilling
Journal:  PLoS One       Date:  2017-04-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.